BL Pharmtech Corp. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 0.00002 million compared to KRW 0.00002 million a year ago.

Net loss was KRW 37.1 million compared to KRW 397.1 million a year ago. Basic loss per share from continuing operations was KRW 1 compared to KRW 4 a year ago. Diluted loss per share from continuing operations was KRW 1 compared to KRW 4 a year ago.

Basic loss per share was KRW 1 compared to KRW 4 a year ago.